| 生物活性 | |||
|---|---|---|---|
| 描述 | NGI-1, also known as ML414, is a potent oligosaccharyltransferase (OST) inhibitor that directly targets and blocks the function of the OST catalytic subunits STT3A and STT3B[1].NGI-1 effectively reduces viral infectivity without affecting cell viability. NGI-1 blocks N-linked glycosylation of EGFR in lung adenocarcinoma cells and results in altered cellular localisation of the EGFR[2]. | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
2.53mL 0.51mL 0.25mL |
12.67mL 2.53mL 1.27mL |
25.35mL 5.07mL 2.53mL |
| 参考文献 |
|---|